Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tenax Therapeutics Inc (NASDAQ:TENX)

3.67
Delayed Data
As of 12:53pm ET
 -0.0121 / -0.33%
Today’s Change
2.88
Today|||52-Week Range
4.76
-4.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues100.5K92.7K25.7K0.00
 
 
 
 
Cost of Goods Sold51.3K43.1K129.8K0.00
 
 
 
 
Depreciation And Amortization206.7K154.0K156.2K148.1K
 
 
 
 
 
 
Operating ExpensesGross Income-157.4K-104.4K-260.3K-148.1K
 
 
 
 
 
General Expenses8.3M6.0M16.6M13.5M
 
 
 
 
 
Research And Development2.5M2.4M3.0M6.6M
 
 
 
 
 
Total Operating Expenses8.6M6.2M16.9M13.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.5M-6.1M-16.9M-13.7M
 
 
 
 
 
Extraordinary Credit0.000.00--382.4K
 
 
Extraordinary Charge-29.5K-248.0K-721.8K-1.2M
 
 
 
 
 
Interest Expense On Debt7.4M4.2M2.2M49.1K
 
 
 
 
 
Other Expenses234.4K1.2M266.4K57.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.7M-9.4M-19.5M-14.1M
 
 
 
 
 
Preferred Dividend0.00-958.1K-5.8M0.00
 
 
 
Net Income-15.7M-9.4M-19.5M-14.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.3M1.7M9.4M28.1M
 
 
 
 
 
Shares To Calculate EPS Diluted1.4M1.8M9.4M28.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$14.00-$133.60-$2.71-$0.50
 
 
 
 
 
EPS Diluted-$14.00-$6.68-$2.71-$0.50